Page 199 - Mployee Wellness Programs News Today

Transcarent recently announced a partnership with The Clinic by Cleveland Clinic, which provides second opinions from medical specialists via video visits. Now Transcarent members can access The Clinic’s services as a benefit, which means they won’t face any out-of-pocket costs in most cases.

Sunnyside is promoting "Dry(ish)" January that promotes drinking in moderation versus complete sobriety. The company offers a direct-to-consumer app that helps users make a plan for their drinking and provides peer coaching.

Small healthcare practices aren't very eager to spend extra cash right now. However, investments in the patient experience could be worth it to give them the upper hand over competitors, according to a new report.

Arrive Health (formerly RxRevu) recently acquired a suite of technology developed at UPMC. The technology suite includes an AI-powered chatbot and customer relationship management platform, both designed to support improved medication adherence and prescription capture rates.

Headspace Health's mindfulness services will now be offered on Gympass' platform. The company has a network of more than 50,000 gyms, classes, trainers and wellbeing apps that it offers to more than 10,000 companies.

A budget estimate attached to proposed legislation in Montana raises questions about whether the state's cash-strapped communities will have the capacity to care for patients with Alzheimer’s disease, other types of dementia or traumatic brain injuries by July 2025, when involuntary commitments would cease under the plan.

Elicio Therapeutics dipped its toe in the IPO waters but decided to go public by merging with publicly traded Angion Biomedica. Clinical-stage Elicio is developing immunotherapies, including cancer vaccines, that work by targeting immune cells located in the lymph nodes.

Medicare Advantage patients with diabetes have higher prescription fill rates, fewer emergency department visits and lower total medical spending than traditional fee-for-service Medicare patients, a new report shows. They also received their diagnosis earlier.

Johnson & Johnson's CEO believes the company will maintain its strong reputation for innovation amid changing economic conditions because of its hefty investments in research and development. He said it's crucial to invest both internally and externally, as some of the most innovative and lucrative opportunities come from outside companies.

Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup’s technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bid to targets previously deemed undruggable.